col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


7 Ergebisse       Seite 1

 [1] 
MDPI AG: BioChem
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Sep―26 Mechanistic Insights into Targeting SARS-CoV-2 Papain-like Protease in the Evolution and Management of COVID-19 Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, Rene B. Khan, Hezekiel M. Kumalo
2 [GO] 2024―Mai―15 Novel Tetrazolium-Based Colorimetric Assay for Helicase nsp13 in SARS-CoV-2 Triet M. Pham, Morgan G. Howard, Shane M. Carey, Lindsey R. Baker, Edward L. D’Antonio
3 [GO] 2022―Apr―19 COVID-19: A Systematic Review of the Transmissibility, Pathogenesis, Entry Factors, and Signature Immune Response Deena Fayyad, Jessica L. Kelts, Tristan H. Nielson, Ibiere Lovelyn Epelle, Nicodemus C. Monear, Miguel T. G. Strawn, et al. (+2)
4 [GO] 2022―Feb―09 Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome Lisa Pagani, Clizia Chinello, Allia Mahajneh, Francesca Clerici, Lucrezia Criscuolo, Andrea Favalli, et al. (+9)
5 [GO] 2021―Dez―02 MALDI MS-Based Investigations for SARS-CoV-2 Detection Mariaimmacolata Preianò, Serena Correnti, Corrado Pelaia, Rocco Savino, Rosa Terracciano
6 [GO] 2021―Nov―15 “Multiomics” Approaches to Understand and Treat COVID-19: Mass Spectrometry and Next-Generation Sequencing Diane Appiasie, Daniel J. Guerra, Kyle Tanguay, Steven Jelinek, Damian D. Guerra, Rwik Sen
7 [GO] 2021―Apr―05 De Novo Drug Design Using Artificial Intelligence Applied on SARS-CoV-2 Viral Proteins ASYNT-GAN Ivan Jacobs, Manolis Maragoudakis
 [1] 

7 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec